| Aug 30 |
Oculis Holding (NASDAQ:OCS) Is In A Good Position To Deliver On Growth Plans
|
| Aug 29 |
Oculis to Present at Upcoming September Investor Conferences
|
| Aug 28 |
Oculis Holding reports Q2 results
|
| Aug 27 |
Oculis files to sell 361,011 ordinary shares for holders
|
| Aug 27 |
Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update
|
| Aug 27 |
Oculis Reports Q2 Financial Results and Provides Recent Company Update
|
| Aug 15 |
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
|
| Jul 30 |
Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
|
| Jun 27 |
Oculis and EURETINA Announces the Ramin Tadayoni Award
|
| Jun 11 |
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
|
